Concepedia
Statistics
Publications
8
Citations
822
H-Index
Active since
2009
Affiliations
University of Oxford(Current)
Ludwig Cancer Research
CRUK/MRC Oxford Institute for Radiation Oncology
Science Oxford
University of Cambridge
Hannah Lingard is an author at University of Oxford specializing in medicinal chemistry, ligand binding, and life sciences.
Publications per year
2009–2016
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
S. Picaud, Christopher Wells, I. Felletar et al. · Proceedings of the National Academy of Sciences · 2013 · 481 citations · Full text
Life Sciences, Molecular Biology, Cell Signaling +11
Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
S. Picaud, Katharina Leonards, Jean‐Philippe Lambert et al. · Science Advances · 2016 · 110 citations · Full text
Medicine, Oncology, Pharmacology +15
[1,2,4]Triazolo[4,3-<i>a</i>]phthalazines: Inhibitors of Diverse Bromodomains
O. Fedorov, Hannah Lingard, Christopher Wells et al. · Journal of Medicinal Chemistry · 2013 · 98 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
Diphenylacetylene‐Linked Peptide Strands Induce Bidirectional β‐Sheet Formation
Hannah Lingard, Jeongmin Han, Amber L. Thompson et al. · Angewandte Chemie International Edition · 2014 · 44 citations
Life Sciences, Biochemistry, Medicinal Chemistry +17
Highly Potent, Orally Available Anti-inflammatory Broad-Spectrum Chemokine Inhibitors
David J. Fox, Jill Reckless, Hannah Lingard et al. · Journal of Medicinal Chemistry · 2009 · 34 citations
Medicine, Medicinal Chemistry, Pharmacology +15
1–5 of 8